| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 08/13/2002 | US6433162 Method for synthesizing porphyrin compounds |
| 08/13/2002 | US6432962 Antiinflammatory agents |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | US6432356 Chemical compound 5,7-diphenyl-1,3-diazoadamantan-6-one, used for antiseptics and peracetic acid |
| 08/13/2002 | CA2216633C Synthesis of bis-indolylmaleimides |
| 08/13/2002 | CA2063955C Pyrrolo(1,2-a)indole hydroxylamine derivatives as inhibitors of leukotriene biosynthesis |
| 08/08/2002 | WO2002060907A1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |
| 08/08/2002 | WO2002060903A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | WO2002060902A1 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060871A2 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 08/08/2002 | WO2002060838A1 Production of fluorine compounds |
| 08/08/2002 | WO2002060492A1 Methods of inhibiting kinases |
| 08/08/2002 | WO2002060449A2 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | WO2002060422A2 Treatment of diabetes mellitus using vardenafil |
| 08/08/2002 | WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK) |
| 08/08/2002 | WO2002060383A2 Cancer therapy |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002018327A3 Guanidinobenzamides as mc4-r agonists |
| 08/08/2002 | WO2002015697A3 Fungicidal formulation |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002008211A3 Benzothiazepines and their use as antihyperlipidemics |
| 08/08/2002 | WO2002000631A3 Benzhydryl derivatives |
| 08/08/2002 | WO2001056555A3 Use of cox-2 inhibitors for the treatment of constipation |
| 08/08/2002 | US20020107402 Aminoaryl oxazolidinone N-oxides |
| 08/08/2002 | US20020107399 1H-pyrrolo-[1,2,-b] [1,2,4] triazole compound and its synthetic intermediate, and method of preparing A 1H-1,2,4-triazole-5-yl-acetic acid |
| 08/08/2002 | US20020107397 Provide polymeric resin products having low polydispersity. |
| 08/08/2002 | US20020107394 Process for the preparation of triethylenediamine (TEDA) |
| 08/08/2002 | US20020107392 Quinolinone derivatives |
| 08/08/2002 | US20020107278 Substituted azepino[4,5b]indole derivatives |
| 08/08/2002 | US20020107256 Polymorphs of N-methyl-N-(3-{3-[2- thienylcarbonyl]-pyrazol-[1,5-alpha]- pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 08/08/2002 | US20020107242 Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 08/08/2002 | US20020107235 Carbamate and hydroxy groups containing phenanthrene derivatives; useful to treat obesity, diabetes and inflammation |
| 08/08/2002 | DE10104663A1 Herstellung von Fluorverbindungen Preparation of fluorine compounds |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk) |
| 08/08/2002 | CA2436576A1 Treatment of diabetes mellitus using vardenafil |
| 08/08/2002 | CA2436487A1 Methods of inhibiting kinases |
| 08/08/2002 | CA2436245A1 Medicament for protection in radiotherapy |
| 08/08/2002 | CA2436209A1 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | CA2434970A1 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
| 08/08/2002 | CA2433351A1 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 08/08/2002 | CA2429969A1 Substituted indolines as 5-ht receptor ligands |
| 08/07/2002 | EP1228072A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 08/07/2002 | EP1228071A1 Pharmaceutically active isoindoline derivatives |
| 08/07/2002 | EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 08/07/2002 | EP1228069A2 Bicyclic and tricyclic heteroaromatic compounds |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228066A2 Sulfonamide derivatives |
| 08/07/2002 | EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227721A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 08/07/2002 | EP1012151B1 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders |
| 08/07/2002 | EP0986562B1 Substituted 1,2,4-triazolo 3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
| 08/07/2002 | EP0888336B1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/07/2002 | CN1362960A Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones |
| 08/07/2002 | CN1362411A Method for preparing tri-ethyl-di-amine (TEDA) |
| 08/07/2002 | CN1362397A Dialkoyl-halogen phenyl substituted keto-enol |
| 08/07/2002 | CN1088713C Ruthenium (II) polypridine match for two-stage PH snsing and its preparing process |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/06/2002 | US6429310 Photonic or electronic energy conducting |
| 08/01/2002 | WO2002059127A2 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists |
| 08/01/2002 | WO2002059126A1 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative |
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059093A1 Methods and compositions for binding nucleic acid molecules |
| 08/01/2002 | WO2002059082A2 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 08/01/2002 | WO2002059076A1 Method for producing dtpa monoamides |
| 08/01/2002 | WO2002059074A1 Benzylamine analogue |
| 08/01/2002 | WO2002058844A1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation |
| 08/01/2002 | WO2002058704A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 08/01/2002 | WO2002028861A3 Methods and compounds for treating proliferative diseases |
| 08/01/2002 | WO2002024226A3 Photosensitisers |
| 08/01/2002 | WO2002014319A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 08/01/2002 | WO2001003126A9 High density non-volatile memory device |
| 08/01/2002 | US20020103374 Spiro quarternary ammonium salt compounds, used as phase transfer catalyst for stereoselective alkylation |
| 08/01/2002 | US20020103371 Substituted imidazo [1,5-a] [1,2,4] triazolo [4,3-d] [1,4] benzodiazepine derivatives |
| 08/01/2002 | US20020103211 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders |
| 08/01/2002 | US20020103210 Nitrogen-containing heterocyclic compounds, their production and use |
| 08/01/2002 | US20020103209 Serotonergic modulators; for treatment of disorders of the central nervous system including psychotic disorders, hypertension and vascular disorders, migraine |
| 08/01/2002 | US20020103203 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 08/01/2002 | US20020103161 Novel heterocycles |
| 08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
| 08/01/2002 | DE10104389A1 Multimere Photosensibilisatoren sowie deren Konjugate für die PDT Multimers photosensitizers and their conjugates for PDT |
| 08/01/2002 | DE10103770A1 Verfahren zur Herstellung von hochreinem Methenamin A process for the production of high purity methenamine |
| 08/01/2002 | DE10103647A1 Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates A process for preparing a pyrazolo (4,3-d) pyrimidine derivative |
| 08/01/2002 | CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2435884A1 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative |
| 08/01/2002 | CA2435883A1 Benzylamine analogue |
| 08/01/2002 | CA2434558A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | CA2432122A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 08/01/2002 | CA2431970A1 Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonists and antagonists |
| 08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | CA2429490A1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation |
| 07/31/2002 | EP1227103A2 Ring-expanded nucleosides and nucleotides |
| 07/31/2002 | EP1227098A1 Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |